Lei Wang
- Cancer Research top 1%
- MicroRNA in disease regulation 29
- Cancer-related molecular mechanisms research 13
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways 23
- Receptor Mechanisms and Signaling 15
- RNA modifications and cancer 14
- Immunology top 5%
- Immune Response and Inflammation 25
- Rheumatology top 2%
- Folate and B Vitamins Research 14
-
- Pancreatic function and diabetes 18
Lei Wang
296 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 1.1k
- Molecular Biology 3.3k
- Immunology 833
- Cardiology and Cardiovascular Medicine 871
- Rheumatology 444
Countries citing papers authored by Lei Wang
This map shows the geographic impact of Lei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wang more than expected).
Fields of papers citing papers by Lei Wang
This network shows the impact of papers produced by Lei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wang. The network helps show where Lei Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 8 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 14 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 22 | |
| 13 | 2019 | 6 | |
| 14 | 2018 | 15 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 23 | |
| 17 | 2017 | 1 | |
| 18 | 2016 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2012 | 45 |
About Lei Wang
Lei Wang is a scholar working on Cancer Research, Cardiology and Cardiovascular Medicine and Immunology, having authored 310 papers that have together received 6.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (29 papers), Immune Response and Inflammation (25 papers), Ubiquitin and proteasome pathways (23 papers), Pancreatic function and diabetes (18 papers), Receptor Mechanisms and Signaling (15 papers), RNA modifications and cancer (14 papers), Folate and B Vitamins Research (14 papers) and Cancer-related molecular mechanisms research (13 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (3.3k citations) and Immunology (833 citations). Lei Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Kent E. Pinkerton, Hui‐Hua Li, Jie Du, Angie L. Bookout, Hiroshi Kurosu, Regina Goetz, Makoto Kuro‐o, Steven A. Kliewer, David J. Mangelsdorf and Klementina Fon Tacer. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.